1
Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder
Condition(s):Opioid-use DisorderLast Updated:July 30, 2021Recruiting
Buprenorphine as an Intervention: 587 Clinical Trials, Page 1 of 59
Hide Studies Not Open or Pending
2
Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology
Condition(s):Opioid-use DisorderLast Updated:March 24, 2020Withdrawn
3
An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder
Condition(s):Opioid-use DisorderLast Updated:March 9, 2021Completed
4
Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure
Condition(s):Neonatal Abstinence Syndrome; Neonatal Opiate Withdrawal SyndromeLast Updated:July 12, 2019Completed
5
Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women
Condition(s):Opioid Use DisorderLast Updated:October 14, 2020Withdrawn
6
Fetal and Infant Effects of Maternal Buprenorphine Treatment
Condition(s):Neonatal Abstinence SyndromeLast Updated:September 26, 2017Completed
7
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
Condition(s):Opioid-use DisorderLast Updated:August 18, 2021Not yet recruiting
8
SUBLOCADE Rapid Initiation Study
Condition(s):Opioid-use DisorderLast Updated:April 15, 2021Completed
9
New Application of Buprenorphine Patch on Painful Knee Joint in Knee Osteoarthritis Patients
Condition(s):Knee OsteoarthritisLast Updated:May 13, 2019Unknown status
10
Extended-release Injectable Buprenorphine for Individuals at High Risk of Overdose
Condition(s):Opioid-Use Disorder; Opioid OverdoseLast Updated:March 25, 2021Not yet recruiting